VENBIO PARTNERS LLC
VENBIO PARTNERS LLC is a Seed, Series A, Series B, Series C+ and other fund in the US, Canada and Netherlands writing $8M–$140M checks into biotechnology, medical-devices, life-sciences and biopharmaceuticals.
- Stages
- Seed, Series A, Series B, Series C+, other
- Sectors
- biotechnology, medical-devices, life-sciences, biopharmaceuticals
- Check size
- $8M–$140M
- Invests in
- US-wide, Canada, Netherlands
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2011
- Assets under management
- $2B
- Website
- venbio.com
Thesis
venBio Partners LLC is a venture capital firm established in 2011, specializing in the life sciences sector, with a focus on biotechnology, medical devices, and biopharmaceuticals. Their core investment thesis is to translate "great science into impactful medicine" by identifying and supporting companies that address unmet medical needs. venBio is stage-agnostic, investing from seed and startup through early-stage, expansion, and late-stage companies, including academic spinouts and PIPE deals. Their typical investment horizon is three to five years, prioritizing companies with strong differentiation, data, and a focus on real diseases. They primarily invest in the United States but also consider companies in Canada and the Netherlands. The typical check size ranges from $8 million, with the capacity to lead larger rounds between $40 million and $140 million.
Common questions
Does VENBIO PARTNERS LLC invest at the Seed stage?
Yes. VENBIO PARTNERS LLC lists Seed, Series A, Series B, Series C+ and other among the stages it invests in.
What check size does VENBIO PARTNERS LLC write?
VENBIO PARTNERS LLC writes $8M–$140M checks.
Where does VENBIO PARTNERS LLC invest?
VENBIO PARTNERS LLC invests in the US, Canada and Netherlands.